Institut Européen des Membranes, IEM, UMR 5635, Univ Montpellier, CNRS, ENSCM, 34095 Montpellier, France.
IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université Montpellier, F-34298 Montpellier, France.
ACS Appl Bio Mater. 2022 Jun 20;5(6):3075-3085. doi: 10.1021/acsabm.2c00345. Epub 2022 May 18.
The aim of this work was the development of injectable radio-opaque and macroporous calcium phosphate cement (CPC) to be used as a bone substitute for the treatment of pathologic vertebral fractures. A CPC was first rendered radio-opaque by the incorporation of zirconium dioxide (ZrO). In order to create macroporosity, poly lactic--glycolic acid (PLGA) microspheres around 100 μm were homogeneously incorporated into the CPC as observed by scanning electron microscopy. Physicochemical analyses by X-ray diffraction and Fourier transform infrared spectroscopy confirmed the brushite phase of the cement. The mechanical properties of the CPC/PLGA cement containing 30% PLGA (wt/wt) were characterized by a compressive strength of 2 MPa and a Young's modulus of 1 GPa. The CPC/PLGA exhibited initial and final setting times of 7 and 12 min, respectively. Although the incorporation of PLGA microspheres increased the force necessary to inject the cement and decreased the percentage of injected mass as a function of time, the CPC/PLGA appeared fully injectable at 4 min. Moreover, in comparison with CPC, CPC/PLGA showed a full degradation in 6 weeks (with 100% mass loss), and this was associated with an acidification of the medium containing the CPC/PLGA sample (pH of 3.5 after 6 weeks). A cell viability test validated CPC/PLGA biocompatibility, and in vivo analyses using a bone defect assay in the caudal vertebrae of Wistar rats showed the good opacity of the CPC through the tail and a significant increased degradation of the CPC/PLGA cement a month after implantation. In conclusion, this injectable CPC scaffold appears to be an interesting material for bone substitution.
本工作旨在开发可注射的放射线阻射性和大孔磷酸钙水泥(CPC),用作病理性椎体骨折的骨替代物。首先通过掺入二氧化锆(ZrO)使 CPC 具有放射线阻射性。为了制造大孔,通过扫描电子显微镜观察到将 100μm 左右的聚乳酸-乙醇酸(PLGA)微球均匀地掺入 CPC 中。X 射线衍射和傅里叶变换红外光谱的物理化学分析证实了水泥的磷酸氢钙相。含有 30%PLGA(wt / wt)的 CPC / PLGA 水泥的力学性能通过 2MPa 的抗压强度和 1GPa 的杨氏模量来表征。CPC / PLGA 表现出分别为 7 和 12min 的初始和最终凝固时间。尽管 PLGA 微球的掺入增加了注射水泥所需的力,并降低了随时间推移而注入质量的百分比,但 CPC / PLGA 在 4min 时似乎完全可注射。此外,与 CPC 相比,CPC / PLGA 在 6 周内完全降解(质量损失 100%),这与 CPC / PLGA 样品所含介质的酸化有关(6 周后 pH 值为 3.5)。细胞活力测试验证了 CPC / PLGA 的生物相容性,并且使用 Wistar 大鼠尾骨中的骨缺损模型进行的体内分析表明 CPC 通过尾巴具有良好的不透明度,并且在植入一个月后 CPC / PLGA 水泥的降解明显增加。总之,这种可注射的 CPC 支架似乎是一种很有前途的骨替代材料。